Navigation Links
Rheumatoid Arthritis a Threat to the Heart
Date:10/27/2008

h rheumatoid arthritis may reveal heart abnormalities before they are detected clinically, Liang said. An echocardiogram is a test that uses sound waves to create a moving picture of the heart, according to the U.S. National Institutes of Health.

Dr. John Hardin, chief science officer at the Arthritis Foundation, said these new studies highlight the toll that rheumatoid arthritis can take on the cardiovascular system.

"These studies are consistent with the idea that systemic inflammation promotes cardiovascular disease," Hardin said. "Rheumatoid arthritis creates a general state of inflammation within the body."

Hardin also noted that some arthritis drugs can increase the risk of heart problems in rheumatoid arthritis patients who already have damaged hearts. "For example, Enbrel (etanercept) can, in fact, in some people, potentiate heart failure, which can be a complication of myocardial infarction," he said.

To prevent a heart attack, patients with rheumatoid arthritis need to pay particular attention to cholesterol, blood pressure and maintaining a healthy lifestyle, Hardin said. "If you have rheumatoid arthritis, the things you do to protect yourself against cardiovascular disease become doubly important," he said.

Rheumatoid arthritis is a chronic disease that results in pain, stiffness, swelling, and limitation in the motion and function of multiple joints. The disease also can cause inflammation in other organs. An estimated 1.3 million Americans suffer from rheumatoid arthritis, according to the Arthritis Foundation.

More information

To learn more about rheumatoid arthritis, visit the U.S. National Library of Medicine.



SOURCES: Hilal Maradit Kremers, M.D., associate professor of epidemiology, Mayo Clinic, Rochester, Minn.; Kimberly Liang, M.D., assistant prof
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Biologic treatment for rheumatoid arthritis and the risk of cancer
2. Genes Boost Risk for Rheumatoid Arthritis, Lupus
3. The genes involved in rheumatoid arthritis identified
4. Genome Area Linked to Rheumatoid Arthritis
5. Meditation therapy for rheumatoid arthritis patients
6. Meditation May Help Rheumatoid Arthritis Sufferers
7. Researchers identify genes that increase rheumatoid arthritis risk
8. The widening mortality gap between people with rheumatoid arthritis and the general population
9. Rheumatoid Arthritis Death Rate Unchanged
10. Drugs Can Ease Juvenile Rheumatoid Arthritis
11. Rheumatoid Arthritis Boosts Heart Disease Threat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... The Triumph Modular, ... practices, consumer education, resource library, floor plans, educational blog and wide use of ... offers regular posts with valuable links to useful reports by industry experts. Comments ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... announces the Lost and Found, a breakthrough technological invention. It is a ... for the consumer electronic industry reached a record high of $211.3 billion in ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Morristown Medical Center, ... Jersey, and one of the first five hospitals in the nation, to implant the ... patients on July 23, and all are in good condition. , The CoreValve® Evolut® ...
(Date:7/28/2015)... ... July 28, 2015 , ... DuPont leaders today ... Ethiopia to learn more about the impact of U.S. collaborations with local partners ... on accelerating agricultural development as an engine of broad-based economic growth in the ...
(Date:7/28/2015)... ... 2015 , ... Women in Technology (WIT), the premier organization contributing to the ... has selected Lisa Dezzutti, CEO and president at Market Connections, Inc. as the organization’s ... this organization that empowers women to thrive and excel in the technology field. In ...
Breaking Medicine News(10 mins):Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2
... , VANCOUVER, June 10 /PRNewswire-FirstCall/ - Response Biomedical Corporation ... Livleen Kaler has been appointed Vice President Finance & ... years of financial management experience in several industries. , ... the Board is pleased to recognize Livleen for her ...
... Trust Inc. (NYSE: CRE ) ("Care" or the ... dividend of $0.17 per share of common stock for the first ... to common shareholders of record on June 23, 2009. , ... Trust Inc. is a real estate investment and finance company investing ...
... One of Bucks County,s largest employers will create more than ... the help of a new state investment in an ongoing ... an $11.1 million grant, on behalf of the Doylestown Hospital, ... , , The funds will be used ...
... statement from the American Chemistry Council regarding papers ... including: "Bisphenol-A Exposure In Utero Leads to Epigenetic ... "Low-Dose Bisphenol A Promotes Arrhythmogenesis in the Female ... Belcher, PhD; and "Oral Exposure of Female Rhesus ...
... find similar results , WEDNESDAY, June 10 (HealthDay News) ... drugs after radiation therapy do better when the drug treatment ... six-month regimen, a European study has found. , The results ... in May, said Dr. Eric M. Horwitz, acting chairman of ...
... Metoclopramide, a drug approved in the U.S. for nausea, ... according to a large cohort study published in the June ... Medicine , "The Safety of Metoclopramide Use in the First ... June 11, 2009). According to the pediatrician and clinical ...
Cached Medicine News:Health News:Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer 2Health News:Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer 3Health News:Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer 4Health News:Care Investment Trust Inc. Announces Quarterly Dividend 2Health News:State to Invest $11.1 Million in Expansion of Doylestown Hospital 2Health News:Press Releases on BPA Studies By-Pass Scientific Process 2Health News:Longer Hormone Treatment May Improve Prostate Cancer Outlook 2Health News:Longer Hormone Treatment May Improve Prostate Cancer Outlook 3Health News:Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchers 2
(Date:7/28/2015)... Transparency Market Research (TMR) has announced ... Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, ... to this report, the global cancer diagnostics market is expected ... period of 2014 to 2020. In 2013, the global cancer ... to be worth US$168,649.3 million by 2020.The increasing prevalence of ...
(Date:7/28/2015)... July 28, 2015   Cynosure, Inc. ... markets medical devices for aesthetic procedures and precision ... the three months ended June 30, 2015. ... of double-digit growth, as revenues increased 47 percent ... Chief Executive Officer Michael Davin. "While our international ...
(Date:7/28/2015)... July 28, 2015  Zipnosis, the first virtual care solution ... to launch their own branded virtual care service line, announced ... CareNow is currently in use. ... As ... many recognize the value of providing their own branded online ...
Breaking Medicine Technology:Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 3Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 4Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 2Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 3Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 4Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 5Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 6Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 7Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 8Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 9Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 10Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 11Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 12Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 13Zipnosis Announces Group Health to use Virtual Care Service Line 2Zipnosis Announces Group Health to use Virtual Care Service Line 3
... and TARRYTOWN, N.Y., Nov. 10, 2011 Sanofi ... and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ... Phase 2 study program in which patients with ... REGN727/SAR236553. REGN727/SAR236553 is a novel, high-affinity, ...
... NASHVILLE, Tenn., Nov. 9, 2011 Revenue ... Non-GAAP Adjusted EBITDA of $76.7 million, increased 15.3% over third ... of healthcare revenue and payment cycle management and clinical information ... ended September 30, 2011, as summarized below: (In millions, except ...
Cached Medicine Technology:Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 2Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 3Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 4Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 5Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 6Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 7Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 8Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 9Emdeon Reports Third Quarter 2011 Results 2Emdeon Reports Third Quarter 2011 Results 3Emdeon Reports Third Quarter 2011 Results 4Emdeon Reports Third Quarter 2011 Results 5Emdeon Reports Third Quarter 2011 Results 6Emdeon Reports Third Quarter 2011 Results 7Emdeon Reports Third Quarter 2011 Results 8Emdeon Reports Third Quarter 2011 Results 9Emdeon Reports Third Quarter 2011 Results 10Emdeon Reports Third Quarter 2011 Results 11Emdeon Reports Third Quarter 2011 Results 12Emdeon Reports Third Quarter 2011 Results 13
Liquichek Therapeutic Drug Monitoring Control (TDM) is a liquid assayed control containing a comprehensive menu of therapeutic drugs, as well as many common ligands. Available in three levels....
Liquichek Serum Volatiles Control is a bilevel liquid control with assayed values for the most widely measured volatile compounds....
Liquichek Urinalysis Control is specifically designed for urine dipstick and microscopic testing. This control provides clear, visual positive and negative results, including hCG (pregnancy) and micr...
qUAntify Plus Control is a combination urine dipstick and microscopic control. The control is available in either 12 mL centrifuge tubes or 120 mL flip-top squeeze bottles....
Medicine Products: